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vs. repulsion) and their different modes of action (diffusion vs. contact) suggests that one may take 61 precedence over the other. The goal of this work was to examine neurotrophin-ephrin interactions, 62 focusing on the effects of BDNF and ephrin-A5 on synaptic activity in cultured embryonic 63 hippocampal neurons. We found that application of either soluble ephrin-A5-Fc or EphA5-Fc 64 elicited a transient increase in ongoing synaptic activity. When tested in combination with BDNF, 65 pre-exposure to ephrin-A5-Fc prevented the effect of BDNF. BDNF, however, had no influence on 66 the response to subsequently applied ephrin-A5-Fc. An analysis of spontaneous transmitter release 67 suggested that the action of ephrin-A5 was presynaptic. This finding was supported by 68 experiments in which interrupting EphA receptor signaling presynaptically rescued the response to 69 Bi et al.
-4 -BDNF. EphA5-Fc also reduced the effect of subsequently applied BDNF, but our experiments 70 suggest that the mechanism is not presynaptic. Taken together, our data indicate that the contact-71 dependent action of ephrin-A5 supercedes the diffusion-based effect of BDNF. 72
METHODS

73
Primary hippocampal cell cultures. Embryonic day 18 fetuses of time-mated pregnant 74
Sprague-Dawley rats were removed in accordance with institution guidelines for the care and use 75 of animals. Fetal hippocampi were dissected and dissociated by trypsinization followed by 76 trituration through fire-polished Pasteur pipettes. Neurons were plated in poly-D-lysine coated mm Nunc dishes at 4 x 10 5 cells/dish. Cultures were maintained in serum-free medium (SFM) 78 composed of a 1:1 mixture of Ham's F-12 and Eagle's MEM supplemented with 25 μg/ml insulin, 79 100 μg/ml transferrin, 60 μM putrescine, 20 nM progesterone, 30 nM selenium, and 6 mg/ml 80 glucose. Cells were grown at 37° C in 5% CO 2 . 81 Electrophysiological recordings. Whole-cell patch clamp recordings were performed after 82 12-14 days in vitro (DIV). Currents were recorded with an Axopatch 200 amplifier, digitized at 2.9 83 kHz and filtered at 5 kHz. Pyramidal-type cells were recorded in voltage clamp mode with Vm set 84 to -50mV. The external bath solution (NRS) was (in mM) 1.67 CaCl 2 , 1 MgCl 2 , 5.36 KCl, 137 NaCl, 85 17 glucose, 10 HEPES and 13.15 sucrose. The pipette solution contained (in mM) 105 Cs-86 methanesulfonate, 17.5 CsCl, 10 HEPES, 0.2 EGTA, 8 NaCl, 2 Mg-ATP, 2 Na 2 -ATP, 0.3 Na 3 -GTP, 87 and 20 phosphocreatine. The pH of the internal solution was set to 7.3 with CsOH. The typical 88 range of pipette resistance was 3-5 MΩ. 20 ng/ml BDNF, 2μg/ml ephrin-A5-Fc, and 2μg/ml 89 EphA5-Fc solutions for perfusion were diluted in NRS. The concentration of BDNF was chosen to 90 favor selective activation of the high-affinity trkB receptor (Chao and Hempstead 1995 initial responses (e.g. the peak response to BDNF subsequent to application of ephrin-A5-Fc) were 106 calculated by taking the percent baseline at the peak response (average percent baseline at 8-9 min) 107 and subtracting from that the percent baseline at the onset of the second perfusion and an offset 108 value used to compensate for the decline in the initial response. Student's t-test was used for 109 statistical comparisons (two-tailed, p < 0.05 indicating significance). 110
Neuronal transfection. To interrupt signaling by ephrin-A5-Fc, cells were transfected with a 111 dominant negative, kinase-deficient EphA DNA construct linked with GFP [EphA5(K-)-GFP or 112
EphA3(K-)-GFP] (Yue et al. 2002) . The neurons were transfected with this construct using the 113 calcium-phosphate method at DIV 5 and were recorded 9 days later. The plasmid-Ca-Pi 114 coprecipitation was carried out on dissociated hippocampal neuronal cultures. Briefly, for each 35 115 mm dish, 3 µg of DNA (at 0.5 µg/µl) was mixed with 2 M CaCl2 and 20 µl sterile water, and then 116 added with 30 µl 2XHBSS by drop while vortexing. 2XHBSS contained 50 mM HEPES, 1.5 mM 280 117 mM NaCl, 10 mM KCl, and 15 mM glucose (all from Sigma). After keeping the DNA mixture for 20 118 minutes precipitation in the dark, cells were washed with DMEM (Sigma) three times, 80% of the 119 medium exchanged each time. 1 ml DMEM was left in the dishes after the final round of washing. 120 60 µl of the DNA-Ca-Pi mixture was added to each dish. Cells were incubated with the DNA for 40 121 minutes in the incubator. The medium was then discarded, the dish washed with SFM three times, 122
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-6 -and incubated for 1 hour at 37° C in 5% CO 2 for the thorough clearing of the remaining DNA-Ca-Pi 123 reagents. Finally, the medium was replaced with the original conditioned medium taken from the 124 original dishes and the cells were returned into the incubator. 125
Biochemistry. Dissociated hippocampal neurons were treated with 20 ng/ml BDNF with or 126 without 2 μg/ml ephrin-A5-Fc for varying time periods. Western blot analysis was used to assess 127 the extent of p42/44 MAPK phosphorylation using a phosphorylation-specific antibody. The blots 128 were then reprobed for total p42/44 MAPK to evaluate relative protein levels. Intensity was 129 quantified with ImageJ. 130
RESULTS
131
Ephrin-A5-Fc and EphA5-Fc increase synaptic activity in embryonic hippocampal neurons. 132
To examine ephrin-BDNF interactions, we first measured the effects of ephrin-A5-Fc or EphA5-Fc 133 alone on synaptic activity in cultured embryonic hippocampal neurons. When placed in tissue 134 culture, hippocampal neurons form networks that exhibit synaptically driven ongoing activity. 135
Whole-cell patch clamp recording was used to measure baseline activity for several minutes until it 136 became stable, following which soluble ephrin-A5-Fc or EphA5-Fc (2 μg/ml) was perfused 137 continuously for 20 minutes (Fig. 1 ). Application of either molecule elicited a transient increase in 138 synaptic activity at short latency. Synaptic charge increased by approximately 50% within one 139 minute of ephrin-A5-Fc application (152 ± 17% of baseline, n = 8), and returned to baseline within 140 10 minutes despite maintained exposure to the ligand ( Fig. 1a, d) . Similarly, application of EphA5-141
Fc produced a rapid doubling of synaptic activity (220 ± 22% of baseline, n = 6) that also decayed to 142 baseline within 10 minutes ( Fig. 1b, e ). In both cases, the elevated activity declined despite the 143 maintained presence of ephrin-A5-Fc or EphA5-Fc. Application of 2 μg/ml Fc fragment alone in 144 vehicle solution had no effect on its own (98.9 ± 11% of baseline, n = 8) or on the response to 145 subsequently applied BDNF (195 ± 20% of baseline, n = 8). This effect was limited to evoked 146 release of transmitter. Measurement of spontaneous miniature currents showed no effect of 147 Bi et al.
-7 -exogenously applied ephrin-A5-Fc or EphA5-Fc, either on event frequency or average current 148 amplitude ( Fig. 1c, f) . 149
Ephrin-A5-Fc inhibits the synaptic actions of BDNF. To study ephrin-BDNF interactions, 150
we used a protocol in which a stable baseline was established for 3 minutes, followed by a 5 minute 151 application of either vehicle or a test molecule, followed by a 15 minute application of a second test 152
molecule. Our initial recordings tested the effect of ephrin-A5-Fc on the already well-characterized 153 response to BDNF (Levine et al. 1995). Application of vehicle for 5 minutes produced no change in 154 synaptic activity, and subsequent application of 20 ng/ml BDNF caused a doubling of synaptic 155 activity (average at 8-9 min: 255 ± 20%, n = 8) that began within a minute of BDNF application, 156 declined slowly, yet remained elevated during the 15 minutes of exposure to BDNF ( Fig. 2a ). This 157 response to BDNF, however, was virtually eliminated by a 5 minute pre-application of ephrin-A5-158 Fc (Fig. 2b) . Instead of the expected doubling of activity, only a slight increase was seen ( Fig. 2c ; 107 159 ± 10%, n = 20). The solid gray line in figure 2b shows the time course predicted if the response to 160 BDNF was added to the response to ephrin-A5-Fc. To ensure that the inhibition of the BDNF 161 response was not exclusive to the specific concentrations that we used or the sequential application 162 procedure, we repeated the experiments with different conditions. First, we used co-application of 163 ephrin-A5-Fc and BDNF [ Fig. 2c , bar labeled "ephr-A5 (+B)"] and found a block of the BDNF effect 164 comparable to that with sequential application (99.9 ± 5.7%, n = 5). In addition, we tested 2 μg/ml 165 ephrin-A5-Fc with 50 ng/ml BDNF and 0.5 μg ephrin-A5-Fc with 20 ng/ml BDNF. For these 166 additional concentrations, the responses were consistent with our initial observations. Despite 167 using the higher concentration of BDNF, the normal enhancement of synaptic activity was virtually 168 eliminated by ephrin-A5-Fc (103 ± 6.8%, n = 6). Even 0.5 μg/ml ephrin-A5-Fc was able to reduce 169 the response to BDNF, although not as completely as 2 μg/ml ephrin-A5-Fc (124 ± 12%, n = 8).
170
The effect of ephrin-A5-Fc on the response to BDNF was not mirrored by reverse application. 171
When a 15 minute exposure to ephrin-A5-Fc was preceded by vehicle, the expected transient 172 increase in activity was observed ( Fig. 2d ; 184 ± 11%, n = 10). When the exposure to ephrin-A5-Fc 173 was preceded by a 5 minute application of BDNF, synaptic activity still increased to a level Bi et al.
-8 -predicted by application of ephrin-A5-Fc alone (163 ± 40%, n = 10). Because the absence of an effect 175 of BDNF on the response to ephrin-A5-Fc could have resulted from washout of BDNF during 176 application of the ephrin, we also used a co-application procedure in addition to sequential 177 application. BDNF was pre-applied followed by co-application of ephrin-A5-Fc and BDNF. In this 178 case, BDNF still failed to change significantly the response to ephrin-A5-Fc ( Fig. 2e, f ; 172 ± 38%, n = 179 5). 180
EphA5-Fc reduces the synaptic actions of BDNF. It is known that ephrin signaling is 181 bidirectional, with both the ligand and receptor able to engage intracellular signaling pathways. 182
We therefore conducted parallel experiments with soluble EphA5-Fc to determine whether binding 183 to ephrin-A ligand could also modulate the synaptic responses to BDNF (Fig. 3) . As with ephrin-184 A5-Fc, pre-exposure to EphA5-Fc reduced the synaptic response to subsequently applied BDNF ( Fig  185   3a ; 153 ± 11%, n = 9; compare to response following vehicle in figure 2a ). For EphA5-Fc, however, 186 the reduction in the BDNF response was less complete and most dramatic toward the end of the 15 187 minute application period. To ensure that the incomplete inhibition was not due to washout of 188 EphA5-Fc during the perfusion of BDNF, we also tested co-application of BDNF and EphA5-Fc after 189 5 min exposure to EphA5-Fc (Fig. 3b ). The response was very similar to that observed with 190 sequential application (178 ± 18%, n = 7). In both cases, the peak response to BDNF was 191 significantly lower following EphA5-Fc application ( Fig. 3c ), although the largest inhibitory effect 192 was observed 12 min after the beginning of BDNF application. 193
To determine whether the response to receptor activation by EphA5 would be inhibited by 194 BDNF, we reversed the order of application. As with ephrin-A5-Fc, however, BDNF did not have a 195 significant effect on the response to EphA5-Fc when applied either sequentially (199 ± 20%, n = 8 vs. 196 169 ± 18%, n = 5) or co-applied ( Fig. 3d-f ; 199 ± 20%, n = 8 vs. 167 ± 29%, n = 9).
197
Inhibitory and excitatory ephrin actions are independent. The experiments described above 198
show that both ephrin-A5-Fc and Eph-A5-Fc elicit an increase in synaptic activity and reduce the 199 response to BDNF. To determine whether these two processes are separable, we increased the 200 interval between addition of ephrin/Eph and exposure to BDNF such that the transient excitatory 201
-9 -response to the former had ended before application of the latter. As shown in figure 1, the 202 increased synaptic activity produced by ephrin-A5-Fc or EphA5-Fc lasted approximately 10 203 minutes, so in these experiments BDNF was not applied until 15 minutes after the onset of 204 ephrin/Eph. To establish a baseline for comparison, cells were exposed to vehicle solution for 15 205 min prior to adding BDNF (Fig. 4a) , and the magnitude of the BDNF effect was quantified at 3-4 206 min after the start of BDNF perfusion (18-19 min into the recording). As expected, synaptic charge 207 increased during the BDNF perfusion (198 ± 16%, n = 10). When ephrin-A5-Fc was applied 15 min 208 before the BDNF, the response to BDNF was virtually eliminated (86 ± 3.8%, n = 6) even though the 209 excitatory action of ephrin-A5-Fc had decayed completely (Fig. 4b) . EphA5-Fc also reduced the 210 response to BDNF even though its excitatory effect was over ( Fig. 4c ; 145 ± 6.4%, n = 10), although and EphA5-Fc may also act at different loci. To gain some understanding of the locus at which 217 ephrin-A5-Fc exerted its effects, we recorded and quantified mPSC frequency. As already shown, 218 when applied for 20 min, neither ephrin-A5-Fc nor EphA5-Fc had a significant effect on mPSC 219 frequency ( Fig. 1c, f) . As expected, however, a 15 minute application of BDNF produced an 220 elevation of mPSC frequency ( Fig. 5a ; 200 ± 16%, n = 7) whereas the preceding application of 221 vehicle had no effect. When applied in tandem with BDNF, an initial 5 min application of ephrin-222 A5-Fc produced no change in mPSC frequency. Surprisingly, subsequent application of BDNF 223 failed to increase mPSC frequency (Fig. 5b, c; 99.3 ± 8%, n = 6). This result suggests that ephrin-A5-
224
Fc prevented the presynaptic effect of BDNF on mPSC frequency, but had little overt effect of its 225
own. 226
We also tested for potential presynaptic effects of EphA5-Fc, and found none. Application of 227 EphA5-Fc had no effect of its own on mPSC frequency and did not alter the response to BDNF ( The rationale for these experiments is that the cell being recorded from would show normal EphA 240 activation whereas EphA receptors in the presynaptic terminals from nearby transfected cells would 241 be inhibited. If the inhibition of the BDNF response by ephrin-A5-Fc is presynaptic, then the net 242 result should be restoration of the response to BDNF due to an absence of inhibition by ephrin-A5-243
Fc. This is what was observed ( Fig. 6a ). Following the initial direct effect of ephrin-A5-Fc, synaptic 244 activity increased upon subsequent application of BDNF. Comparison of the responses to earlier 245 recordings ( Fig. 2b) shows clearly that there was a substantial recovery of the BDNF-induced 246 increase in synaptic charge. This suggests that signaling by presynaptic EphA receptors was 247 prevented, thus interrupting presynaptic inhibition by ephrin-A5-Fc and enabling BNDF activation 248 of trkB to produce an increase in synaptic activity. These experiments also indicate that the 249 mechanism of the trkB inhibition is via trkB-initiated signaling cascades and not by binding of 250 ephrin-A5-Fc to trkB itself, which would not be expected to be prevented by transfection of the 251
EphA(K-) constructs. 252
These experiments also imply that the direct effect of ephrin-A5-Fc does not have a 253 presynaptic origin because it remains intact despite inhibition of presynaptic EphA receptors. To 254 investigate whether postsynaptic transfection could interfere with the direct effect of ephrin-A5-Fc 255 Bi et al.
-11 -we recorded from transfected cells that were in regions of the tissue culture dish with no other 256 transfected cells nearby. In these recordings, the direct effect of ephrin-A5-Fc was not observed, nor 257 was the response to subsequently applied BDNF (Fig. 6b) . In other words, although the direct 258 excitatory effect of ephrin-A5-Fc did not occur, presumably because postsynaptic EphA receptors 259 were inhibited, BDNF modulation was still prevented, presumably via normal EphA signaling in 260 the untransfected presynaptic cells. providing further support for the idea that this action is either triggered or manifested 268 postsynaptically (Fig. 6c) . These experiments showed that treatment with 20 ng/ml BDNF alone increased the level of p42/44 277 MAPK phosphorylation in hippocampal neurons (Fig. 7a , middle lane) compared to the constitutive 278 phosphorylation level in the absence of any treatment (Fig. 7a, left lane) . As predicted from our 279 electrophysiological recordings, co-application of 2 μg/ml ephrin-A5-Fc, reduced this 280 phosphorylation (Fig. 7a, right lane) . Quantification from 4 separate experiments showed the 281 reproducibility of this effect (Fig. 7b) . 282
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DISCUSSION
283
The central finding of this study is that with regard to effects on synaptic transmission in the 284 embryonic hippocampus, the contact-triggered action of ephrin-A prevents the diffusion-mediated 285 effect of BDNF. Similarly, exposure to EphA5-Fc reduces the action of subsequently applied BDNF, 286 although lack of effect on spontaneous mPSCs suggests that the mechanism is different than that of We chose to study ephrin-As because we were interested in antagonistic interactions, and and may be a key to signal integration between different receptors. Together, these observations 393 suggest that Eph receptors converge onto the Erk/MAPK pathway to modulate trk receptor 394 activity. The mechanism by which this occurs is likely to be complex, with direct interaction of 395 between those studies and this, however, is that the effects we observe are non-reciprocal. Our 401 working hypothesis is that contact-mediated interactions overrule diffusion-mediated ones. 402
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